Simple Summary Risk stratification for early breast cancer (BC) is extremely relevant for
tailoring clinical decisions but challenging due to the absence of comprehensive guidelines …

Breast cancer (BC), one of the most widespread and devastating diseases affecting women
worldwide, presents a significant public health challenge. This review explores the emerging …

Simple Summary Risk assessment in early breast cancer is critical for clinical decisions, but
defining risk categories poses a significant challenge. The integration of conventional …

Transcription factors (TFs) have been shown to play a key role in the occurrence and
development of tumors, including triple-negative breast cancer (TNBC), with a worse …

Triple-negative breast carcinoma (TNBC) is one of the most challenging subtypes of breast
carcinoma and it has very limited therapeutic options as it is highly aggressive. The …

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with high
immunogenicity. In this study, we developed a peptide-modified cyclodextrin-based …

PD-L1 test is recommended in different types of tumors to select patients eligible for immune
checkpoint inhibitors (ICI) therapy. Several factors make this test challenging in metastatic …

Background Breast cancer, particularly triple-negative breast cancer (TNBC), poses a
significant global health burden. Chemotherapy was the mainstay treatment for TNBC …

This review paper highlights the role of phytocannabinoids in controlling triple-negative
breast cancer (TNBC). Triple-negative breast cancer (TNBC) is a specific subtype of breast …